Cat. No. 5288
Chemical Name: 4-[2-Fluoro-5-[3-(6-methyl-2-pyridi
Biological ActivityPotent and selective inhibitor of the TGF-β type I receptor/ALK5 (IC50 = 2.5 nM). Exhibits ~5000-fold selectivity over p38 MAPK. Suppresses development of renal fibrosis in a unilateral ureteral obstruction model. Also reduces proteinuria, glomerulosclerosis and improves renal function in an anti-Thy1 glomerulonephritis model. Orally bioavailable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Terashima et al (2014) R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. Eur.J.Pharmacol. 734 60. PMID: 24726873.
If you know of a relevant reference for R 268712 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses R 268712 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: R 268712, supplier, R268712, potent, selective, inhibitors, inhibits, TGF-βRI, TGF-β, TGF-betaRI, TGFbRI, TGFbR1, tgf-b1, ALK5, ALK, receptors, activin, receptor-like, Kinases, transforming, growth, factor, β, kidney, Tocris Bioscience, TGF-β Receptor Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective inhibitor of TGF-βRILDN 214117
Potent and selective ALK2 inhibitorLDN 212854
Potent bone morphogenetic protein type I (ALK) inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.